Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. [electronic resource] by
- Chouela, E
- Abeldaño, A
- Panetta, J
- Ducard, M
- Neglia, V
- Sookoian, S
- Kina, M
- Castaño, G
- Vereytou, F
- Frider, B
Producer: 19970225
In:
International journal of dermatology vol. 35
Availability: No items available.
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials. [electronic resource] by
- Strober, B E
- Gottlieb, A B
- van de Kerkhof, P C M
- Puig, L
- Bachelez, H
- Chouela, E
- Imafuku, S
- Thaçi, D
- Tan, H
- Valdez, H
- Gupta, P
- Kaur, M
- Frajzyngier, V
- Wolk, R
Producer: 20191120
In:
The British journal of dermatology vol. 180
Availability: No items available.
|